Well, we agree that P16 is a promising technology, and hopefully one that Amarantus can add to their portfolio. My point in making the original post was that I found it funny that joboggi would comment on how impressed he was with P16 after ridiculing the company's data presented, and now we get a PR that Amarantus has the exclusive option to license P16. Who knows? Perhaps one day he will actually be a company supporter rather than a basher with an agenda. It will be interesting to see if his outlook on P16 changes if the company does license it.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links